Digg It - Internet and Businesses Online

Email invitations are by far the most common method of releasing a survey to respondents. For most people who use email for work, anything received more t

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

han a day ago does not appear on the first screen of their in-box. People tend to check email as it arrives. If they do not immediately click on the link

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

to enter your survey having read the message, few will return in the following days to do so as the invite will be off the front page.

Most people manage

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

to at least scan through their mail every three days. If however if you have been away, often Monday there will be a bit of catch up.

It is important to

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

remember 90% of people, who are ever going to respond, do it the first time they read the invitation. Response rate patterns are then more reflective of e

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

mail reading patterns than any choice of respondents. It is then vital to have the invitation designed as the best call to action. More on this in another

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

article.

All the percentages quoted here are of the total responses received, including follow-ups and are based on a review of a large number of on-lin

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

e surveys.

The first hour is key. With email released surveys, on average 12% of all responses are received in the first hour. This may differ depending

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

n the specific timing (eg. out of office hours) or audience (eg. Non-employees), but certainly holds true in business based users during normal business h

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ours.

By the end of the first day you will have received about 30% of your total responses. This will have been the highest day by far. The specific numb

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

er of responses will be a reflection of the invite and survey experience.

Day two and three will be significantly lower at around 6% of total responses a

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

s people get to reviewing their email and responding on first read. For the rest of the week, responses fall to only 3% of total responses on average. By

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

he end of week one you will have received 60%.

Often a follow up email is sent after a week. The response to the first follow up is surprisingly the same

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

as day two responses, around 6% of total. Second follow-ups only average a 3% response.

Due mainly to the 'holiday' scenario as well as the typical prac

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

tice of follow-up emails, 80% of all responses received are in by the end of the second week. Often after two weeks, the effort to chase further responses

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

starts to wane.

It is clear that for most surveys a two week run is sufficient. Responses do keep flowing in, but even after a month. Only 90% of respon

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

es are received, the remaining 10% dribbling in over the following month.

So there you have it. Now after just one day you will be able to estimate your

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

total responses. If that number does not seem high enough you will need to reassess the three main drivers of response and look to see what can be changed

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

:

1. The release - call to action
2. The respondent level of engagement
3. The responding experience
(These will be covered in a later art

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

icle.)

If you have any topics you would like covered please mail me at SteveWrightMail@gmail.com and I will include them in my growing list.

Cheers Stev

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/68771/diggit-When-Will-I-Know-My-Response-Rate-of-an-Online-Survey.html">When Will I Know My Response Rate of an Online Survey?</a>

BB link (for phorums):
[url=http://www.diggit.org.ua/article/68771/diggit-When-Will-I-Know-My-Response-Rate-of-an-Online-Survey.html]When Will I Know My Response Rate of an Online Survey?[/url]

Expense report forms are the formats to be filled out by an employee for claiming reimbursement of expenses of official or personal visit. Every organization will have its own format. It is advisable to use an expense report form rather than simply listing out all the expenses in an Excel sheet and submit that. Through the form, both the employee and the employer are in a position to have a clear-cut idea as to how much money is involved in the form of expenses so that reimbursement will be quickened. Thus, the process of expense reporting starts with filling out the expense report form. Some organizations have online versions of these expense reports in which the employees need to enter all the data and send it to the Accounting Department.

If you are considering starting a business making a business plan is a good idea. A professional business plan can help you become more successful in your business. All businesses plans have an executive summary.

People who join pharmacy affiliate programs expect large gains over a little amount of time and not without foundation. Pharmacy affiliate programs are among the top paying affiliate programs and it's expected that the number of people who will make their pharma purchases on the internet will increase exponentially in the years to come. So if you want to make money online really fast, joining a pharmacy affiliate program should be a good idea.

Tags

Links

Digg It - When Will I Know My Response Rate of an Online Survey?

Related Articles: